Citigroup (C): Rebounding Return on Tangible Common Equity Anchors Long-Term Thesis Soumya Eswaran Mon, October 12, 2026 at 10:52 AM EDT 3 min read C +0.54% ^GSPC -0.01% SPGI +1.28% Explore stocks on Coinbase Trading disclosure Trading disclosure The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Patient Capital Management, based in Baltimore, released its third-quarter 2026 investor letter for the "Patient Opportunity Equity Strategy". The letter can be downloaded here. The Opportunity Equity Strategy outperformed the S&P 500 in the latest quarter, gaining 4.32% compared to 2.30%, and is up 14.93% year-to-date versus the index's 12.75%. The market shows resilience, despite rate increases presenting risks and opportunities. The current market is seen as part of a long bull run, especially since March 2009, with the S&P compounding at 16.9% per year. The AI revolution adds complexity, and investor skepticism persists amidst rising valuations, yet strong corporate earnings suggest potential. The focus remains on understanding price expectations and evaluating risks, particularly around AI durability and supply-demand for computing capacity. The portfolio is concentrated in top 10 holdings, suggesting a disciplined approach towards valuation and risk management amidst market volatility. Also, check the strategy's top five holdings to see its best picks in 2026.
In its Q3 2026 investor letter, Patient Opportunity Equity Strategy highlighted Citigroup Inc. (NYSE:C). Citigroup Inc. (NYSE:C) is a diversified financial services holding company. On October 09, 2026, Citigroup Inc. (NYSE:C) closed at $129.64 per share. Over the past month, Citigroup Inc. (NYSE:C) declined 4.80%, but its shares are up 34.90% over the past year. Citigroup Inc. (NYSE:C) has a market capitalization of $217.46 billion, and its stock has traded within a 52-week range of $95.00 to $147.96.
Patient Opportunity Equity Strategy stated the following regarding Citigroup Inc. (NYSE:C) in its Q3 2026 investor letter:
"Citigroup Inc. (NYSE:C) (C $128.08) is another of our significant winners as CEO Jane Fraser successfully executed a turnaround. We don't think the work is done. Return on tangible common equity should be 11.5% in 2026, up from 2023's trough of 4.8%. We expect it to rise to the mid-teens by the end of the decade, which should support stock gains in the mid-teens per year as well. The current valuation at 10x 2027 earnings is undemanding."
Citigroup Inc. (NYSE:C) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. According to our database, 102 hedge fund portfolios held Citigroup Inc. (NYSE:C) at the end of the second quarter, compared to 106 in the previous quarter. While we acknowledge the potential of Citigroup Inc. (NYSE:C) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
In another article, we discussed Citigroup Inc. (NYSE:C) and shared a list of best undervalued stocks to buy in October. In addition, please check out our hedge fund investor letters Q3 2026 page for more investor letters from hedge funds and other leading investors.
This article is originally published at Insider Monkey.
